Schlüsselwörter
(Deutsch)
|
Tanzania, SMS for Life, SMS4life, Novartis, Vodafone, Malaria, Medicines for Malaria Venture (MMV)
|
Schlüsselwörter
(Englisch)
|
Tanzania, SMS for Life, SMS4life, Novartis, Vodafone, Malaria, Medicines for Malaria Venture (MMV)
|
Schlüsselwörter
(Französisch)
|
Tanzania, SMS for Life, SMS4life, Novartis, Vodafone, Malaria, Medicines for Malaria Venture (MMV)
|
Schlüsselwörter
(Italienisch)
|
Tanzania, SMS for Life, SMS4life, Novartis, Vodafone, Malaria, Medicines for Malaria Venture (MMV)
|
Kurzbeschreibung
(Deutsch)
|
The lack of available Artemisinin-based Combination Therapies (ACTs) continues to hinder effective treatment of malaria in many countries. To address this issue, in 2009 a partnership between the Government of Tanzania, the Roll Back Malaria Partnership (RBM), Novartis, Vodafone, and IBM implemented a pilot called “SMS for Life” in three health districts in Tanzania. Using SMS, health facilities reported on stock levels of anti-malarials, which provided transparency on the level of stock and on stock-outs. Following the pilot, the partnership decided to scale up SMS for Life to the national level. This evaluation reviewed the national scale-up process and the outcomes SMS for Life has achieved since the scale-up.This evaluation shows that the technical platform works well and health facilities are able to provide stock information reliably. However, the national scale-up has also shown that management and integration of such a system at the national level is challenging. SMS for Life was implemented successfully as a technical tool, but the scale-up’s supply chain outcomes have been less encouraging. This may in part be due to national ACT shortages that occurred at the same time as the national scale-up, or to the system’s segregation from upstream supply chain management and other facility-level programs, which inhibits its utility in resolving supply bottlenecks effectively. In order to create lasting and sustainable impact, the Government needs to decide how it will manage the pharmaceutical supply chain going forward and what role SMS for Life should play in the process.
Zugehörige Dokumente
|
Kurzbeschreibung
(Englisch)
|
The lack of available Artemisinin-based Combination Therapies (ACTs) continues to hinder effective treatment of malaria in many countries. To address this issue, in 2009 a partnership between the Government of Tanzania, the Roll Back Malaria Partnership (RBM), Novartis, Vodafone, and IBM implemented a pilot called “SMS for Life” in three health districts in Tanzania. Using SMS, health facilities reported on stock levels of anti-malarials, which provided transparency on the level of stock and on stock-outs. Following the pilot, the partnership decided to scale up SMS for Life to the national level. This evaluation reviewed the national scale-up process and the outcomes SMS for Life has achieved since the scale-up.This evaluation shows that the technical platform works well and health facilities are able to provide stock information reliably. However, the national scale-up has also shown that management and integration of such a system at the national level is challenging. SMS for Life was implemented successfully as a technical tool, but the scale-up’s supply chain outcomes have been less encouraging. This may in part be due to national ACT shortages that occurred at the same time as the national scale-up, or to the system’s segregation from upstream supply chain management and other facility-level programs, which inhibits its utility in resolving supply bottlenecks effectively. In order to create lasting and sustainable impact, the Government needs to decide how it will manage the pharmaceutical supply chain going forward and what role SMS for Life should play in the process.
Zugehörige Dokumente
|
Kurzbeschreibung
(Französisch)
|
The lack of available Artemisinin-based Combination Therapies (ACTs) continues to hinder effective treatment of malaria in many countries. To address this issue, in 2009 a partnership between the Government of Tanzania, the Roll Back Malaria Partnership (RBM), Novartis, Vodafone, and IBM implemented a pilot called “SMS for Life” in three health districts in Tanzania. Using SMS, health facilities reported on stock levels of anti-malarials, which provided transparency on the level of stock and on stock-outs. Following the pilot, the partnership decided to scale up SMS for Life to the national level. This evaluation reviewed the national scale-up process and the outcomes SMS for Life has achieved since the scale-up.This evaluation shows that the technical platform works well and health facilities are able to provide stock information reliably. However, the national scale-up has also shown that management and integration of such a system at the national level is challenging. SMS for Life was implemented successfully as a technical tool, but the scale-up’s supply chain outcomes have been less encouraging. This may in part be due to national ACT shortages that occurred at the same time as the national scale-up, or to the system’s segregation from upstream supply chain management and other facility-level programs, which inhibits its utility in resolving supply bottlenecks effectively. In order to create lasting and sustainable impact, the Government needs to decide how it will manage the pharmaceutical supply chain going forward and what role SMS for Life should play in the process.
Zugehörige Dokumente
|
Kurzbeschreibung
(Italienisch)
|
The lack of available Artemisinin-based Combination Therapies (ACTs) continues to hinder effective treatment of malaria in many countries. To address this issue, in 2009 a partnership between the Government of Tanzania, the Roll Back Malaria Partnership (RBM), Novartis, Vodafone, and IBM implemented a pilot called “SMS for Life” in three health districts in Tanzania. Using SMS, health facilities reported on stock levels of anti-malarials, which provided transparency on the level of stock and on stock-outs. Following the pilot, the partnership decided to scale up SMS for Life to the national level. This evaluation reviewed the national scale-up process and the outcomes SMS for Life has achieved since the scale-up.This evaluation shows that the technical platform works well and health facilities are able to provide stock information reliably. However, the national scale-up has also shown that management and integration of such a system at the national level is challenging. SMS for Life was implemented successfully as a technical tool, but the scale-up’s supply chain outcomes have been less encouraging. This may in part be due to national ACT shortages that occurred at the same time as the national scale-up, or to the system’s segregation from upstream supply chain management and other facility-level programs, which inhibits its utility in resolving supply bottlenecks effectively. In order to create lasting and sustainable impact, the Government needs to decide how it will manage the pharmaceutical supply chain going forward and what role SMS for Life should play in the process.
Zugehörige Dokumente
|
Auftragnehmer
(Englisch)
|
Dalberg Global Development Advisors
|
Belastetes Budget
(Englisch)
|
SDC / DEZA / DDC / DSC / COSUDE
|
Gesetzliche Grundlage
(Englisch)
|
Artikel 170 der Bundesverfassung zur WirksamkeitsüberprüfungArticle 170 de la Constitution fédérale relatif à l’évaluation de l’efficacitéArticolo 170 della Costituzione federale sulla verifica dell‘efficaciaArticle 170 of the Swiss Federal Constitution on the evaluation of effectiveness
|
Impressum
(Englisch)
|
Copyright, Bundesbehörden der Schweizerischen Eidgenossenschaft | Droits d'auteur: autorités de la Confédération suisse | Diritti d'autore: autorità della Confederazione Svizzera | Dretgs d'autur: autoritads da la Confederaziun svizra | Copyright, Swiss federal authorities
|
Auskunft
(Englisch)
|
Division Eastern and Southern Africa, Department Regional Cooperation
|
